AQR Capital Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.18K | Buy |
15,705
+255
| +2% | +$84 | ﹤0.01% | 3290 |
|
|
2025
Q1 | $4.82K | Buy |
15,450
+4,811
| +45% | +$1.5K | ﹤0.01% | 3149 |
|
|
2024
Q4 | $9.93K | Buy |
+10,639
| New | +$9.93K | ﹤0.01% | 2855 |
|
|
2021
Q3 | – | Sell |
-301,767
| Closed | -$1.18M | – | 2304 |
|
|
2021
Q2 | $1.18M | Buy |
301,767
+179,708
| +147% | +$703K | ﹤0.01% | 1512 |
|
|
2021
Q1 | $491K | Buy |
122,059
+91,672
| +302% | +$369K | ﹤0.01% | 1848 |
|
|
2020
Q4 | $70K | Sell |
30,387
-20,247
| -40% | -$46.6K | ﹤0.01% | 2166 |
|
|
2020
Q3 | $291K | Buy |
+50,634
| New | +$291K | ﹤0.01% | 1920 |
|